Product Description
| Brand | Zybio |
| Sample Type | Plasma |
| Pack Size | 2 x 50T |
| CAT No | 0601701 |
| Application | Tumor Marker |
ZYBIO CLIA Cancer Antigen (CA 19-9) reagent kit is designed for accurate quantitative determination of CA 19-9 levels using chemiluminescent immunoassay technology. CA 19-19 CLIA reagent is intended to aid in the monitoring of pancreatic cancer, evaluation of treatment response, and detection of disease recurrence.Accurate Cancer Marker DetectionThe ZYBIO EXI CA 19-9 CLIA Analyzer offers precise quantification of the Cancer Antigen 19-9, a key marker in the management and diagnosis of various gastrointestinal cancers. Its use of Chemiluminescence Immunoassay ensures reliable and sensitive detection, providing essential data for patient care and treatment planning.
Automatic and Real-Time OperationFeaturing a fully automatic operating type and real-time data output, this analyzer streamlines laboratory workflow, reducing manual intervention and enhancing productivity. Its portable design makes it easy to deploy in various laboratory settings, ensuring flexibility and efficiency in cancer antigen testing.
Wide Reach and Easy DistributionManufactured and supplied within India, the ZYBIO EXI CA 19-9 Analyzer is available through a comprehensive network of dealers, distributors, exporters, and wholesalers. Laboratories can source this robust and new equipment easily, gaining access to advanced technology for cancer diagnostics.
FAQ's of ZYBIO EXI Cancer Antigen 19-9 [CA 19-9] (CLIA):
Q: How does the ZYBIO EXI CA 19-9 CLIA Analyzer detect the Cancer Antigen 19-9?
A: The analyzer leverages Chemiluminescence Immunoassay (CLIA) technology to identify and quantify CA 19-9 levels in patient samples, providing high sensitivity and specificity essential for early cancer detection and ongoing patient monitoring.
Q: What benefits does the automatic and real-time operation provide in daily laboratory use?
A: Automatic and real-time operation streamlines workflows by reducing manual intervention, enabling rapid processing of samples, and providing immediate results for timely clinical decisions.
Q: When should the ZYBIO EXI CA 19-9 Analyzer be used in patient care?
A: This analyzer is typically used whenever there is a need to determine or monitor the levels of CA 19-9 in patients, particularly those under evaluation for gastrointestinal cancers or during follow-up care for known malignancies.
Q: Where can laboratories in India purchase the ZYBIO EXI CA 19-9 CLIA Analyzer?
A: The analyzer is widely available throughout India via established dealers, distributors, manufacturers, exporters, suppliers, and wholesalers, ensuring accessibility across various regions.
Q: What are the storage instructions for this analyzer to maintain its performance?
A: For optimal performance and longevity, the ZYBIO EXI CA 19-9 CLIA Analyzer should be stored at temperatures between 2 to 8 degrees Celsius, as specified by the manufacturer.
Q: What is the process for testing samples using this CLIA analyzer?
A: Laboratory personnel need to prepare patient samples and load them into the analyzer, which then uses its automatic operation to carry out the chemiluminescence immunoassay and delivers precise results in real time.
Q: How does the portable design benefit laboratory operations?
A: Its portable build allows convenient relocation and flexibility in laboratory setups, enabling use in diverse clinical environments without requiring extensive infrastructure modifications.